Working with global strategic partners in manufacturing, distribution and sales, Investigen will develop smartDNA applications that will revolutionize molecular diagnostics. This new approach to DNA/RNA detection will reduce the dependency on other expensive and cumbersome DNA test methods and will put DNA testing in a portable package that delivers near instantaneous results. smartDNA takes the test out of the lab and into the field.

The power of smartDNA lies in it's simplicity. We will develop unique smartDNA test strips that react to the presence of target nucleic acid sequences - without the need for amplification; a change in color indicates that the target is present.

In the growing field of therapy-specific diagnostics (theranostics), simple to use smartDNA test strips will provide near instantaneous results for genomic testing in the doctor's office, allowing healthcare professionals to optimize the therapeutic regimen for each individual patient.

Whether designed to detect an infectious agent or identify a specific type of cancer, smartDNA is fast, easy to use, and sensitive.

smartDNA is ideal for on-site detection and identification of genetic disorders, infectious diseases, cancer, food- or water-borne pathogens, agro- and bio-terror agents, and related detection applications.

Strategic Partnerships, Licensing, and Custom Development

Investigen will work closely with global strategic partners in all fields of interest to develop unique applications of the smartDNA technology.  Interested parties should contact us for further information.